The days 24 and 25 March of 2025 in the Podgorica (Montenegro) the Management Committee and Working Groups Meeting organised in the framework of the took place Action COST CA21154 took place: Translational control in Cancer European Network (TRANSLACORE).
This even, held by the University of Montenegro, has brought together experts and collaborators to debate the advances, challenges and opportunities in the translational research of control in the context of cancer. In words of Paula Alepuz:
TRANSLACORE has as objective improve further than the actual state of science through the creation of a solid and dynamic committee dedicated to move basic scientific discoveries in the growing area of the synthesis of proteins towards medical applications.
Paula Alepuz, principal researcher of the research group Eukaryotic Gene Expression Research Group: from DNA to Proteins (EGE-DtoP), participated in an intervention called: "“Transcriptional functions of the translation elongation factor eIF5A”, in the third session from 24 March, with other researchers of high level.
COST (European Cooperation of Science and Technology) is a financial agency of research and innovative networks. Their actions help to connect initiatives of research in all Europe and allow the scientific community grow their ideas by sharing then with other teams, pushing their research, their career and their innovation. (https://www.cost.eu)
The Action of Costes TRANSLACORE build bridges between disciplines and specialised knowledge in Europe in order to progress in the emergent field of cancer biology: the translational control of cancer
